JPS5467089A - Urokinase composition - Google Patents

Urokinase composition

Info

Publication number
JPS5467089A
JPS5467089A JP13381277A JP13381277A JPS5467089A JP S5467089 A JPS5467089 A JP S5467089A JP 13381277 A JP13381277 A JP 13381277A JP 13381277 A JP13381277 A JP 13381277A JP S5467089 A JPS5467089 A JP S5467089A
Authority
JP
Japan
Prior art keywords
urokinase
pref
sulfuric acid
composition
acid salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13381277A
Other languages
Japanese (ja)
Inventor
Terukazu Tanaka
Yasuhiro Tsukamasa
Hirokazu Makita
Hiroshi Hozumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainippon Pharmaceutical Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Priority to JP13381277A priority Critical patent/JPS5467089A/en
Publication of JPS5467089A publication Critical patent/JPS5467089A/en
Pending legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PURPOSE: To provide a urokinase composition which is composed of urokinase and chondroitin sulfuric acid salt, and is useful as a remedy for thrombosis, stable as solution or as powder, free from adsorption of urokinase to the wall of the vessel, and easily dissolved in water to form an injection.
CONSTITUTION: A stabilized injection or eye drop containing urokinae and ≥0.02 mg. pref. 0.08W10 mg, esp. 0.15W5 mg, based on 100 IU of urokinase, of chondroitin sulfuric acid salt (pref. Na salt).
COPYRIGHT: (C)1979,JPO&Japio
JP13381277A 1977-11-07 1977-11-07 Urokinase composition Pending JPS5467089A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13381277A JPS5467089A (en) 1977-11-07 1977-11-07 Urokinase composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13381277A JPS5467089A (en) 1977-11-07 1977-11-07 Urokinase composition

Publications (1)

Publication Number Publication Date
JPS5467089A true JPS5467089A (en) 1979-05-30

Family

ID=15113609

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13381277A Pending JPS5467089A (en) 1977-11-07 1977-11-07 Urokinase composition

Country Status (1)

Country Link
JP (1) JPS5467089A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6411000A (en) * 1987-07-01 1989-01-13 Chemo Sero Therapeut Res Inst Controlled serum containing human enzyme and production therof
JPH0418032A (en) * 1989-09-21 1992-01-22 Mitsui Toatsu Chem Inc Fibrinolytic agent containing tissue plasminogen activator or derivative thereof
EP0540747A1 (en) * 1991-04-22 1993-05-12 Senju Pharmaceutical Co., Ltd. Medicine for intraocular operation
AU2002215334B2 (en) * 2000-10-13 2005-11-10 The Johns Hopkins University Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6411000A (en) * 1987-07-01 1989-01-13 Chemo Sero Therapeut Res Inst Controlled serum containing human enzyme and production therof
JPH0418032A (en) * 1989-09-21 1992-01-22 Mitsui Toatsu Chem Inc Fibrinolytic agent containing tissue plasminogen activator or derivative thereof
EP0540747A1 (en) * 1991-04-22 1993-05-12 Senju Pharmaceutical Co., Ltd. Medicine for intraocular operation
AU2002215334B2 (en) * 2000-10-13 2005-11-10 The Johns Hopkins University Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery

Similar Documents

Publication Publication Date Title
JPS5212860A (en) Level detector
JPS5236106A (en) Liquid detergent composition
JPS53109555A (en) Preparation of modified keratin-containing material
JPS5467089A (en) Urokinase composition
JPS557246A (en) Foamable bath salt having improved storage stability
JPS5352622A (en) Composition for preparation of bordeaux mixture
JPS5228507A (en) Detergent composition
JPS5525460A (en) Preparation of red dye
JPS5312414A (en) Production of preparation containing stable 1alpha-hydroxyvitamines d
JPS52143285A (en) Stabilization of cholesterol-oxydase
JPS51146422A (en) Preparation of sulfochloride
JPS5288577A (en) Treatment of waste liquid containing fluorine
JPS5285061A (en) Removal of fluorine ions in solution containing conc. silicic acid
JPS5344572A (en) 5-alkoxy-picolic acid, its preparation and hypotensives containing the same
JPS5382660A (en) Extracting and separating method of metal by liquid-liquid extraction
JPS5220533A (en) Collision detection apparatus
JPS5283413A (en) Preparation of 3,3-dimethyl-4-pentenoic acid or its esters
JPS537662A (en) Preparation of injection containing stable dehydroepiandrosterone sulfate
JPS52143973A (en) Production of electrolytic solution
JPS5214913A (en) Preventive method from corrosion in inside of tank
JPS5226550A (en) Composite stabilizer compositions
JPS5225379A (en) Three-dimensional automtic wrehouse having fumigating chamber
JPS5277393A (en) Structure formed with hole for distributing stress
JPS52138477A (en) Separation of calcium from liquid containing calcium and magnesium
JPS5341414A (en) Hydrate crystals of carbocromene hydrochloride